News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BGI's Shenzhen IPO Rejected By China Regulators



11/4/2016 9:22:54 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
The latest IPO proposal from BGI, China's giant genomic sequencing company, was rejected by Shenzhen's Chi-Next Exchange, according to a report from ChinaMoneyNetwork.com. The problem? Insufficient documentation. In December 2015, BGI submitted an application to IPO two of its merged divisions: BGI Dx (pre-natal genomic testing) and BGI Tech (contract sequencing). The company hoped to raise $260 million at a valuation of $3 billion.

Read at ChinaBio Today


comments powered by Disqus
BGI
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES